Neogen (NEOG)
(Delayed Data from NSDQ)
$15.60 USD
-1.21 (-7.20%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $15.59 -0.01 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Income Statements
Fiscal Year end for Neogen Corporation falls in the month of May .
All items in Millions except EPS data.
5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | |
---|---|---|---|---|---|
Sales | 924 | 822 | 527 | 468 | 418 |
Cost Of Goods | 460 | 416 | 284 | 253 | 222 |
Gross Profit | 464 | 406 | 243 | 215 | 196 |
Selling & Adminstrative & Depr. & Amort Expenses | 405 | 368 | 184 | 141 | 129 |
Income After Depreciation & Amortization | 59 | 38 | 59 | 74 | 68 |
Non-Operating Income | 0 | -4 | 2 | 1 | 5 |
Interest Expense | 73 | 56 | 0 | 0 | 0 |
Pretax Income | -14 | -22 | 60 | 75 | 72 |
Income Taxes | -5 | 1 | 12 | 14 | 13 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -9 | -23 | 48 | 61 | 59 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -9 | -23 | 48 | 61 | 59 |
Depreciation Footnote | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 183 | 129 | 82 | 95 | 86 |
Depreciation & Amortization (Cash Flow) | 125 | 91 | 24 | 21 | 18 |
Income After Depreciation & Amortization | 59 | 38 | 59 | 74 | 68 |
Earnings Per Share Data | 5/31/24 | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 |
---|---|---|---|---|---|
Average Shares | 216.48 | 188.88 | 108.02 | 107.12 | 105.72 |
Diluted EPS Before Non-Recurring Items | 0.45 | 0.56 | 0.63 | 0.57 | 0.57 |
Diluted Net EPS (GAAP) | -0.04 | -0.12 | 0.45 | 0.57 | 0.57 |
Fiscal Year end for Neogen Corporation falls in the month of May .
All items in Millions except EPS data.
8/31/24 | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | |
---|---|---|---|---|---|
Sales | NA | 236.79 | 228.81 | 229.63 | 228.99 |
Cost Of Goods | NA | 123.31 | 111.93 | 112.86 | 112.23 |
Gross Profit | NA | 113.48 | 116.88 | 116.77 | 116.76 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 100.44 | 104.86 | 102.31 | 97.62 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 13.04 | 12.02 | 14.46 | 19.14 |
Non-Operating Income | NA | -0.82 | 0.44 | -0.18 | 0.98 |
Interest Expense | NA | 18.62 | 18.29 | 18.03 | 18.46 |
Pretax Income | NA | -6.40 | -5.82 | -3.75 | 1.66 |
Income Taxes | NA | -0.98 | -3.80 | -0.26 | 0.16 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -5.42 | -2.02 | -3.49 | 1.50 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -5.41 | -2.02 | -3.49 | 1.50 |
Earnings Per Share Data | 8/31/24 | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 216.61 | 216.60 | 216.41 | 216.85 |
Diluted EPS Before Non-Recurring Items | NA | 0.10 | 0.12 | 0.11 | 0.11 |
Diluted Net EPS (GAAP) | NA | -0.02 | -0.01 | -0.02 | 0.01 |